プロバイオティクスは白血病患者の化学療法による合併症を 軽減できるのでしょうか? ランダム化制御試験の体系的レビューとメタ解析
Miaomiao Chen1, Hongyan Lan1, Jiali Huang1
1Nuclear Radiation Injury Protection and Treatment Department, Navy Medical Center of PLA, Shanghai, China.
まとめ
プロバイオティクスのサプリメントは,白血病患者の吐き気や下痢などの化学療法による副作用を適度に軽減します. これらの効果を確認するには,さらなる大規模な試験が必要です.
科学分野:
- 腫瘍学
- 胃腸内科
- 微生物学
背景:
- 化学療法による白血病の治療は しばしば重大な副作用をもたらします
- これらの合併症の管理は,患者の健康と治療の順守に不可欠です.
- プロバイオティクスは,治療に関連する毒性を軽減する可能性を調査しています.
研究 の 目的:
- 化学療法による合併症の管理におけるプロバイオティクスの有効性と信頼性を体系的に評価する.
- この集団におけるプロバイオティクスの使用に関する臨床実務のための根拠に基づいた勧告を提供すること.
主な方法:
- ランダム化対照試験 (RCT) の包括的なメタ解析が行われました.
- 研究は,広範なデータベース検索 (PubMed,Embase,Web of Scienceなど) によって特定されました. 2024年3月まで
- データ合成と品質評価 (GRADE) は,専門的な統計ソフトウェア (RevMan 5. 4 , STATA 15. 0) を使用して行われました.
主要な成果:
- 753人の患者を対象とした8つのRCTを分析した.
- プロバイオティクスは,通常の治療と比較して,吐き気,化学療法による下痢,腫れ,嘔吐,消化不良を大幅に軽減しました.
- また,プロカルシトニンと腫瘍死滅因子アルファのレベルも改善された.
結論:
- プロバイオティクスのサプリメントは,白血病患者のいくつかの化学療法による合併症の緩和に適度な効果を示しています.
- 特定の副作用の管理に プロバイオティクスの使用を支持する高品質の証拠があります
- 小規模なサンプルサイズなどの研究制限により,これらの発見を検証するためにさらなる大規模なRCTが必要である.
さらに関連する動画
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
440
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
440
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Survival Analysis
453
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
453


